Ellidag Hamit Yasar, Aydin Ozgur, Eren Esin, Yilmaz Necat, Ergin Merve
Central Laboratories of Antalya Education and Research Hospital of Ministry of Health, Antalya, Turkey E-mail :
Asian Pac J Cancer Prev. 2014;15(22):9847-51. doi: 10.7314/apjcp.2014.15.22.9847.
Multiple myeloma (MM) is a haematological cancer characterized by clonal proliferation of plasma cells.The aim of this study was to investigate the activity of serum paraoxonase-1 (PON1) and arylesterase (ARE) in multiple myeloma with and without free light chain excretion(FLCe-MM and NFLCe-MM); as well as to investigate possible alterations in oxidative stress parameters.
Total thiol (T.thl), oxidative stress index (OSI), total oxidant status (TOS) and total antioxidant status (TAS) were examined in addition to the PON1 and ARE enzyme activities in twenty one FLCe-MM and nineteen NFLCe-MM subjects. Routine parameters like lipid panel, serum total protein, albumin, creatinine, blood urea nitrogen (BUN), uric acid and hemoglobin levels were compared with the oxidative stress markers.
Serum total protein, BUN, creatinin, and uric acid levels were significantly higher (p=0.04, p=0.001, p=0.001 and p=0.0022, respectively), while hemoglobin and albumin levels were significantly lower in FLCe-MM patients (p=0.009 and p=0.04,respectively). PON1 and ARE activities were significantly lower in patients with FLCe-MM compared to those with NFLCe-MM (p=0.001 and p=0.008, respectively).
Depending on our results of prognostic markers of MM such as age, hemoglobin, albumin, and creatinine we feel confident to presume FLCe-MM as a subgroup with a worse prognosis. A decrease in PON1 and ARE activities may contribute to the prognosis and may be used as a prognostic tool in MM.
多发性骨髓瘤(MM)是一种以浆细胞克隆性增殖为特征的血液系统癌症。本研究旨在调查有或无游离轻链排泄的多发性骨髓瘤患者(FLCe-MM和NFLCe-MM)血清对氧磷酶-1(PON1)和芳基酯酶(ARE)的活性;并研究氧化应激参数的可能变化。
除了检测21例FLCe-MM患者和19例NFLCe-MM患者的PON1和ARE酶活性外,还检测了总巯基(T.thl)、氧化应激指数(OSI)、总氧化剂状态(TOS)和总抗氧化剂状态(TAS)。将血脂、血清总蛋白、白蛋白、肌酐、血尿素氮(BUN)、尿酸和血红蛋白水平等常规参数与氧化应激标志物进行比较。
FLCe-MM患者的血清总蛋白、BUN、肌酐和尿酸水平显著更高(分别为p = 0.04、p = 0.001、p = 0.001和p = 0.0022),而血红蛋白和白蛋白水平显著更低(分别为p = 0.009和p = 0.04)。与NFLCe-MM患者相比,FLCe-MM患者的PON1和ARE活性显著更低(分别为p = 0.001和p = 0.008)。
根据我们关于MM预后标志物(如年龄、血红蛋白、白蛋白和肌酐)的研究结果,我们有信心推测FLCe-MM是一个预后较差的亚组。PON1和ARE活性的降低可能影响预后,并可作为MM的一种预后工具。